Circulating microRNAs as Biomarkers of COVID-19 Severity

L. Pinilla, I. Benítez, A. Carratalá, A. Moncusí-Moix, C. Gort-Paniello, M. Molinero, J. González, G. Torres, M. Bernal, S. Pico, C. Doncel, R. Almansa, N. Jorge, E. Bustamante, J. Gómez, M. González-Rivera, D. Micheloud, P. Ryan, L. Tamayo, C. AldecoaR. Ferrer, A. Ceccato, L. Fernández, A. Motos, J. Riera, R. Menéndez, D. García, O. Peñuelas, A. Torres, J. Bermejo-Martin, F. Barbé, D. de Gonzalo-Calvo

Research output: Contribution to journalMeeting Abstractpeer-review

Abstract

RATIONALE: The identification of minimally invasive and easily-accessible biomarkers to support the management of coronavirus disease 2019 (COVID-19) in hospitalized patients constitutes a hot topic in clinical research. MicroRNAs (miRNAs) have been proposed as clinical indicators to assist in medical decision-making. Here, we aimed to examine the circulating miRNA profile of hospitalized COVID-19 patients and to evaluate its potential as a source of biomarkers for the management of the disease.
Original languageEnglish
Pages (from-to)A2530
Number of pages1
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume203
DOIs
Publication statusPublished - May 2021
Externally publishedYes
EventAmerican Thoracic Society 2021 International Conference - Virtual
Duration: 14 May 202119 May 2021

Keywords

  • MicroRNA
  • coronavirus (COVID-19)
  • Biomarkers
  • Hospitalized patients

Fingerprint

Dive into the research topics of 'Circulating microRNAs as Biomarkers of COVID-19 Severity'. Together they form a unique fingerprint.

Cite this